Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer

BACKGROUND: Increased breast cancer screening over the past four decades has led to a substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions precede invasive ductal carcinoma (IDC), they do not always transform into cancer. The current standard-of-care for DCIS i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ropri, Ali S., DeVaux, Rebecca S., Eng, Jonah, Chittur, Sridar V., Herschkowitz, Jason I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557595/
https://www.ncbi.nlm.nih.gov/pubmed/34717732
http://dx.doi.org/10.1186/s13058-021-01479-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557595/
https://www.ncbi.nlm.nih.gov/pubmed/34717732
http://dx.doi.org/10.1186/s13058-021-01479-8

Ejemplares similares